FIELD: medicine, infections. SUBSTANCE: vaccine preparation has Vi-antigen from Salmonella typhi treated with ribonucleases and pronase and purified by gel-filtration and sodium hydrogen phosphate and sodium ortho-phosphate and phenol for preserving. Immunogenic properties of preparation are similar to that of foreign analogue and can be used successfully as a specific protecting agent at typhoid fever. EFFECT: enhanced effectiveness of preparation. 8 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ISOLATION OF BIOACTIVE FRACTION (BAF) CONTAINING S-LIPOPOLYSACCHARIDES (S-LPS) FROM GRAM-NEGATIVE BACTERIA, BAF FOR PREVENTION AND TREATMENT OF DISEASES INDUCED BY ENDOTOXIC S-LPS PRODUCING GRAM-NEGATIVE BACTERIA, PHARMACEUTICAL COMPOSITION, METHODS FOR INDUCING OF PROTECTIVE IMMUNITY AND IMPROVING STATE IN PATIENT IN NEED OF IMMUNE STATUS INCREASING | 2002 |
|
RU2260053C2 |
| METHOD OF VI-ANTIGEN PREPARING | 1993 |
|
RU2088244C1 |
| LOW-TOXIC, LOW-PYROGENIC LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDES | 1998 |
|
RU2161037C2 |
| HAEMOPHILUS INFLUENZAE B N 326 BACTERIAL STRAIN, STABLE PRODUCER OF CAPSULAR SACCHARIDE | 2011 |
|
RU2465316C1 |
| STRAIN OF BACTERIUM SHIGELLA SONNEI, PHASE 1, STABLE PRODUCER OF S-LIPOPOLYSACCHARIDE | 2001 |
|
RU2241031C2 |
| Shigella flexneri № 1605-8 BACTERIAL STRAIN, SEROTYPE 2a, DEPOSITED IN FEDERAL STATE INSTITUTION TARASEVICH STATE INSTITUTION OF STANDARTISATION AND CONTROL, NO 285, STABLE S-LIPOPOLYSACCHARIDE PRODUCER | 2009 |
|
RU2415921C1 |
| METHOD FOR PRODUCING A COMPLEX SHIGELLOSIS DRUG | 2015 |
|
RU2614123C1 |
| VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
| METHOD OF ANTIBODIES TEST TO CAPSULAR POLYSACCHARIDE Haemophillus influenzae TYPE b | 2006 |
|
RU2331075C2 |
| METHOD OF PRODUCING PROTECTIVE PROTEIN CONTAINING FRACTION OF BACTERIA | 2013 |
|
RU2533815C1 |
